What’s Going On With Eli Lilly Stock Today?
Eli Lilly's stock surge, driven by the upcoming Q4 2023 results and the impact of FDA-approved weight-loss drug Zepbound.
Enbridge’s ‘Once-In-A-Generation Opportunity’ Triggers Golden Cross Ahead Of Q4 Earnings
Enbridge (ENB) stock shows signs of renewed investor confidence ahead of earnings.
Elanco Animal Health To Offload Aqua Business For $1.3B, Plans To Lower Debt Burden
"Merck Animal Health expands aqua portfolio with the $1.3 billion acquisition of Elanco's aqua business. Expected completion by mid-2024."
Weight Loss Drug’s New Entrant: Amgen To Compete With Novo Nordisk, Eli Lilly, As Investigational Weight Loss Drug Shows Encouraging Early Data
Amgen's AMG 133 data. Promising results in obesity drug trials, including significant weight loss and improved metabolic markers.
Spotlight On Spotify’s Q4 Earnings: Restructuring Initiatives, Strategic Investments In AI In Focus
Spotify will report fourth-quarter earnings on Feb. 6. Wall Street expects a negative 14 cents in EPS and $4.06 billion in revenues.
Why Food Giant Tyson Shares Are Surging Today
Tyson Foods (TSN) sees a 0.4% Y/Y sales increase to $13.32 billion in Q1 FY24, surpassing consensus. Sales volume shifts in Beef, Pork, Chicken, and Prepared Foods drive varied performance, while adjusted EPS of $0.69 beats estimates, boosting investor confidence.
China Market Rout Continues, With Small Caps Feeling The Pain Despite Beijing’s Intervention
China pledges more support for the markets and bans exchanges from lending shares for short selling.
Why Cosmetics Major Estee Lauder Shares Are Rocketing Premarket Monday
Estee Lauder (EL) shares surge premarket as Q2 FY24 results surpass expectations. Despite a 7% sales decline, solid earnings and a quarterly dividend of $0.66 per share signal resilience. The company revised FY24 outlook, announcing a Profit Recovery Plan for FY25-FY26, projecting substantial benefits and a focus on consumer-facing activities.
Burger Giant McDonald’s Q4 International Revenue Lags Due To Middle East Tensions, Although Higher Menu Prices Help Top Line
McDonald's Q4 2023 results: Adjusted EPS beats at $2.95, sales of $6.41B, up 8% Y/Y. Strong U.S. same-store sales and global growth.
Why Insurance Company Loews’ Shares Are Rising Premarket Monday
Loews Corp (NYSE: L) announces robust Q4 FY23 results with a net income of $446 million, up from $355 million last year. Higher EPS at $1.99, a significant increase from the previous year's $1.49, showcases the company's resilience. CNA Financial Corp's increased revenue contribution and Boardwalk Pipelines' growth contribute to Loews' solid performance.